Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135061) titled 'A Clinical Study of Rapamycin for the Treatment of Poor Platelet Recollection Following Allogeneic Hematopoietic Stem Cell Transplantation' on Oct. 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Guangxi Medical University
Condition:
Poor platelet recovery after transplantation
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-11-01
Target Sample Size: Single Group: Treatment with Ropustine:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=346552
Disclaimer: C...